Growth Hormone Deficiency – Patient Worthy

Rare Community Profiles: Dr. Pisit “Duke” Pitukcheewanont Discusses Phase 2 Results in LUM-201 for Pediatric Growth Hormone Deficiency

Post author:Jessica Lynn
Post published:February 6, 2024
Post category:Growth hormone deficiency Pediatric Growth Hormone Deficiency (GHD)

Rare Community Profiles is a Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their families, advocates, scientists, and more.…

source: shutterstock.com

Promising Results from Pediatric Growth Hormone Deficiency Phase 2 Trial

Post author:James Moore
Post published:June 23, 2023
Post category:Growth hormone deficiency

According to a story from healio.com, an oral medication being evaluated in a phase 2 study was able to increase annualized height velocity in children living with growth hormone deficiency,…

source: pixabay.com

Sogroya Now Approved for Pediatric Growth Hormone Deficiency (GHD)

Post author:Jessica Lynn
Post published:May 3, 2023
Post category:Pediatric Growth Hormone Deficiency (GHD)

In July 2022, Patient Worthy reported on data from the Phase 3 REAL 4 clinical trial. During the trial, researchers compared the safety, efficacy, and tolerability of Sogroya (somapacitan-beco)…

source: unsplash.com

ICYMI: Evaluating Sogroya for Pediatric Growth Hormone Deficiency

Post author:Jessica Lynn
Post published:July 6, 2022
Post category:Growth hormone deficiency Pediatric Growth Hormone Deficiency (GHD)

The ENDO 2022 Annual Congress took place from June 11-14, 2022. During the Congress, stakeholders met to discuss care, treatments, and research within endocrinology. In a news release from…

source: pixabay.com

Promising Findings in Growth Hormone Deficiency Clinical Trial

Post author:James Moore
Post published:June 30, 2022
Post category:Growth hormone deficiency

According to a story from Globe Newswire, the global healthcare company Novo Nordisk recently announced encouraging findings from its phase 3 clinical trial. This study was evaluating somapacitan (marketed as…

Study: Lonapegsomatropin for Pediatric Growth Hormone Deficiency Patients

Post author:Kendall Mason
Post published:June 8, 2022
Post category:Growth hormone deficiency

Chinese patients living with pediatric growth hormone deficiency are one step closer to a new treatment option, according to a recent article from PharmaBiz.com. The step I'm referring to is…

https://pixabay.com/en/measure-tape-measure-health-fitness-289399/

Study Evaluates rhGH For Children with ISS and GHD

Post author:Alyssa Stevens
Post published:April 21, 2022
Post category:Growth hormone deficiency

According to a recent article, the results of a new study show that using recombinant human growth hormone to treat children with idiopathic short stature and growth hormone deficiency aids…

https://pixabay.com/en/denied-insurance-rejected-stamp-1936877/

FDA Rejects Growth Hormone Deficiency Drug

Post author:Kendall Mason
Post published:February 16, 2022
Post category:Pediatric Growth Hormone Deficiency (GHD)

Despite undergoing clinical development, many drugs never receive approval from the FDA. Recently, this happened to a treatment for growth hormone deficiency (GHD). The medication, titled somatrogon and owned by…

source: pixabay.com

New Once a Week Therapy For Growth Hormone Deficiency is FDA Approved

Post author:Trudy Horsting
Post published:September 24, 2021
Post category:Growth hormone deficiency

The FDA has recently approved Skytrofa as a treatment for children at least one year of age who are facing growth failure as a result of an inadequate secretion of…

Source: Pexels.com

HGF Begins a New Online Support Group around GHD

Post author:Jessica Lynn
Post published:August 13, 2021
Post category:Dwarfism Growth hormone deficiency

As many people within the rare disease or chronic illness community know, having support is crucial and important. Being able to find support means that you find others with…

source: pixabay.com

Ways to Support Those with Pediatric Growth Hormone Deficiency

Post author:Trudy Horsting
Post published:April 28, 2021
Post category:Growth hormone deficiency Pediatric Growth Hormone Deficiency (GHD)

Growth hormone deficiency (GHD) influences patients both physically and mentally. The condition means patients' bodies don't produce enough growth hormone. As a result, they don't develop the same way as…

Phase 3 Trial for Pediatric Growth Hormone Deficiency in China Completed Enrollment On Time Despite COVID-19 Setback

Post author:Trudy Horsting
Post published:April 27, 2021
Post category:Pediatric Growth Hormone Deficiency (GHD)

VISEN Pharmaceuticals has recently announced that enrollment has been completed for their Phase 3 clinical trial examining the safety and efficacy of TransCon hGH compared to daily rhGH in patients…

Free-Photos / Pixabay

An Experimental Treatment for Growth Hormone Deficiency Performs Well in Phase 3 Trial

Post author:James Moore
Post published:October 28, 2019
Post category:Growth hormone deficiency

According to a story from globenewswire.com, the experimental drug somatrogon, which is being co-developed by Pfizer, Inc. and OPKO Health, Inc., was able to achieve its primary endpoint in a…

https://pixabay.com/en/chain-metal-chain-link-257490/

How is Friedreich’s Ataxia Linked to Inflammatory Bowel Disease and Growth Hormone Deficiency?

Post author:Patient Worthy Contributor
Post published:March 15, 2017
Post category:Friedreich ataxia

Friedreich's ataxia (FA) is a rare and painful disease. With few treatments available to treat the genetic mutation, most therapy is aimed at controlling symptoms. Clearly, these short-term band-aids aren't…

Rare Community Profiles: Dr. Pisit “Duke” Pitukcheewanont Discusses Phase 2 Results in LUM-201 for Pediatric Growth Hormone Deficiency

Promising Results from Pediatric Growth Hormone Deficiency Phase 2 Trial

Sogroya Now Approved for Pediatric Growth Hormone Deficiency (GHD)

ICYMI: Evaluating Sogroya for Pediatric Growth Hormone Deficiency

Promising Findings in Growth Hormone Deficiency Clinical Trial

Study: Lonapegsomatropin for Pediatric Growth Hormone Deficiency Patients

Study Evaluates rhGH For Children with ISS and GHD

FDA Rejects Growth Hormone Deficiency Drug

New Once a Week Therapy For Growth Hormone Deficiency is FDA Approved

HGF Begins a New Online Support Group around GHD

Ways to Support Those with Pediatric Growth Hormone Deficiency

Phase 3 Trial for Pediatric Growth Hormone Deficiency in China Completed Enrollment On Time Despite COVID-19 Setback

An Experimental Treatment for Growth Hormone Deficiency Performs Well in Phase 3 Trial

How is Friedreich’s Ataxia Linked to Inflammatory Bowel Disease and Growth Hormone Deficiency?

Let’s Work Together!

Keep Up to Date

Learn More